{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:40:41Z","timestamp":1770986441428,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/gme.0b013e31814fae5d","type":"journal-article","created":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T07:19:20Z","timestamp":1210144760000},"page":"570-574","source":"Crossref","is-referenced-by-count":27,"title":["Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells"],"prefix":"10.1097","volume":"15","author":[{"given":"Candace E.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Ellersieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman M.","family":"Hyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210227","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer Statistics, 2006.","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"R2-28-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogens plus progestins in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R3-28-20210227","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R4-28-20210227","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/edrv-11-2-266","article-title":"Progestin regulation of cellular proliferation.","volume":"11","author":"Clarke","year":"1990","journal-title":"Endocr Rev"},{"key":"R5-28-20210227","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jsbmb.2005.09.008","article-title":"Progestin inhibition of cell death in human breast cancer cells lines.","volume":"98","author":"Moore","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R7-28-20210227","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.00931","article-title":"Sex steroid regulation of vascular endothelial growth factor in breast cancer.","volume":"13","author":"Hyder","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"R8-28-20210227","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-06-0427","article-title":"Natural and synthetic progestins accelerate 7,12-dimethylbenza anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.","volume":"12","author":"Benakanakere","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R9-28-20210227","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.1236","article-title":"Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.","volume":"92","author":"Hyder","year":"2001","journal-title":"Int J Cancer"},{"key":"R10-28-20210227","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/en.2005-0103","article-title":"Proliferation of endothelial and tumor epithelial cells by progestin-induced VEGF from human breast cancer cells: paracrine and autocrine effects.","volume":"146","author":"Liang","year":"2005","journal-title":"Endocrinology"},{"key":"R11-28-20210227","first-page":"146","article-title":"The molecular biology of RU486. Is there a role for anti-progestins in the treatment of breast cancer?","volume":"12","author":"Howtitz","year":"1992","journal-title":"Endocr Rev"},{"key":"R12-28-20210227","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.lfs.2005.12.007","article-title":"Multiple biological activities of curcumin: a short review.","volume":"78","author":"Maheshwari","year":"2006","journal-title":"Life Sci"},{"key":"R13-28-20210227","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3181\/00379727-217-44247","article-title":"Estrogen and progestin bioactivity of foods, herbs, and spices.","volume":"217","author":"Zava","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"R14-28-20210227","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.106-1533252","article-title":"The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids.","volume":"106","author":"Verma","year":"1998","journal-title":"Environ Health Prospect"},{"key":"R15-28-20210227","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/14796694.1.3.405","article-title":"Chemopreventive properties of curcumin.","volume":"1","author":"Campbell","year":"2006","journal-title":"Future Oncol"},{"key":"R16-28-20210227","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3835(96)04224-3","article-title":"Inhibition of 7,12-dimethylbenzaanthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin.","volume":"103","author":"Singletary","year":"1996","journal-title":"Cancer Lett"},{"key":"R17-28-20210227","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ijc.10183","article-title":"Curcumin exerts multiple suppressive effects on human breast carcinoma cells.","volume":"98","author":"Shao","year":"2002","journal-title":"Int J Cancer"},{"key":"R18-28-20210227","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00031305.1981.10479327","article-title":"Rank transformations as a bridge between parametric and nonparametric statistics.","volume":"35","author":"Conover","year":"1981","journal-title":"Am Statist"},{"key":"R20-28-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(99)00109-4","article-title":"Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.","volume":"154","author":"Bentel","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"R21-28-20210227","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/erc.1.01221","article-title":"Vascular endothelial growth factors induce proliferation of breast cancer cells and inhibit the anti-proliferative activity of anti-hormones.","volume":"13","author":"Liang","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"R22-28-20210227","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/me.2004-0252","article-title":"Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.","volume":"19","author":"Wu","year":"2005","journal-title":"Mol Endocrinol"},{"key":"R23-28-20210227","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/me.2006-0304","article-title":"Progestin effects on breast cancer cell proliferation, protease activation, and in vivo development of metastatic phenotype all depend on PR capacity to activate cytoplasmic signaling pathways.","volume":"21","author":"Carnevale","year":"2007","journal-title":"Mol Endocrinol"},{"key":"R24-28-20210227","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1073\/pnas.0336132100","article-title":"Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes.","volume":"100","author":"Zhu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-28-20210227","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/me.2005-0243","article-title":"Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term.","volume":"20","author":"Karteris","year":"2006","journal-title":"Mol Endocrinol"},{"key":"R26-28-20210227","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/gme.0b013e31814fae5d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:52:23Z","timestamp":1738209143000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200815030-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31814fae5d","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}